Abstract
Psychotic-like behaviour was induced in rats with a single i.p. injection of AMPH (20 mg/kg b.w.) and/or PCP (10 mg/kg b.w.). The D1 and D2 dopamine receptor (DAR) specific binding of [3H]SCH 23390 and [3H]spiperone, respectively, during the 120 min period upon the treatment was examined on cryosections using computerized scanning and image analysis. AMPH, alone or in combination with PCP, induced a transient decrease of the D1 receptor specific binding in the striatum (30 min; AMPH, -18%; AMPH+PCP, -31%) and nucleus accumbens (30 min; AMPH, -30%; AMPH+PCP, -40%), which was completely abolished at the 120 min point. Only AMPH persistently elevated nigral D1 receptor specific binding. PCP-induced striatal and accumbal D1 receptor down-regulation was intensive throughout the 120 min period, while in the s. nigra it was non-significant. A significant increase of the D2 receptor specific binding was observed only 30 min after the treatment in striatum (AMPH, 15%; PCP, 16%; AMPH+PCP, 13%) and n. accumbens (AMPH, 16%). These alterations of DAR specific binding may reflect a regulation of the DAR and the changes in nigrostriatal and mesolimbic DA-ergic neurotransmission during an intensive drug-induced psychotic-like behavioral expres...Continue Reading
References
Apr 1, 1992·Neuroendocrinology·D BironT Di Paolo
Jan 1, 1992·Neuroscience·A MansourS J Watson
Jan 1, 1991·Neuroscience·A A Grace
Apr 1, 1990·Neuropharmacology·C D ChapmanS G Howard
Feb 1, 1988·Journal of Neurochemistry·S P ButcherG W Arbuthnott
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G MengodJ M Palacios
Jun 1, 1986·Brain Research·T E Robinson, J B Becker
Jan 20, 1987·Brain Research·T SharpU Ungerstedt
Jan 1, 1974·Journal of Psychiatric Research·B AngristS Gershon
Jun 5, 1980·Nature·S H Snyder
Feb 1, 1994·Acta Physiologica Scandinavica·S M LillrankU Ungerstedt
Oct 1, 1994·Japanese Journal of Pharmacology·K KitaichiT Nabeshima
Sep 17, 1993·Brain Research·K WedzonyK Gołembiowska
May 28, 1993·Brain Research·R E Steinpreis, J D Salamone
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A I LeveyB J Ciliax
Aug 1, 1994·Clinical Neuropharmacology·R B RosseS I Deutsch
Jan 1, 1995·Behavioural Pharmacology·F. Sams-Dodd
Citations
Apr 2, 2003·Pharmacology, Biochemistry, and Behavior·Ratna Sircar, Karam F A Soliman
Feb 17, 2000·Neurochemistry International·M Tomić, J Joksimović
Jun 5, 2003·NeuroImage·Erkki TupalaJari Tiihonen
Dec 19, 2013·PloS One·Somayeh JafariFrancesca Fernandez-Enright
Dec 8, 2007·Psychiatry Research·Erkki Tupala, Jari Tiihonen
Dec 29, 2004·Brain Research·Erkki Tupala, Jari Tiihonen
Dec 14, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Erkki Tupala, Jari Tiihonen
Aug 1, 2011·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Victoria S Dalton, Katerina Zavitsanou
Jun 24, 2008·The International Journal of Neuropsychopharmacology·Abesh K BhattacharjeeStanley I Rapoport
Oct 14, 2014·Psychopharmacology·Jenni VanhanenPertti Panula
Dec 29, 2000·Molecular Psychiatry·J N WorsleyS J Kish
Jan 1, 2017·EJNMMI Radiopharmacy and Chemistry·Maarten OomsGuy Bormans
Jun 13, 2021·Molecular Psychiatry·Milky KohnoWilliam F Hoffman